Company / SG&A per Share
Barinthus Biotherapeutics plc. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.01
FY2025
5-year range
$0.17 / $1.32
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.17 to $1.01 over the past 2 years.
Based on SEC 10-K filings.
1.01 in FY2025 with a 3-year CAGR of +14.5%.
Increased from $0.17 to $1.01 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 1.6% year-over-year.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.01 | -1.6% |
| FY2024 | $1.03 | +507.6% |
| FY2023 | $0.17 | -74.9% |
| FY2022 | $0.68 | -48.7% |
| FY2021 | $1.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026